Skip to content
healthcare.dev

Gefitinib

NDC 67184-0531, Gefitinib, tablet, coated, from Qilu Pharmaceutical Co., Ltd..

Product NDC
67184-0531
Status
Listed
Labeler
Qilu Pharmaceutical Co., Ltd.
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211591
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0531 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GEFITINIB250 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
67184-0531-16718405310130 TABLET, COATED in 1 BOTTLE (67184-0531-1)
67184-0531-267184053102500 TABLET, COATED in 1 BOTTLE (67184-0531-2)
67184-0531-3671840531033 BLISTER PACK in 1 CARTON (67184-0531-3) / 10 TABLET, COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0afc12dd-12f8-4def-9027-f38412a862b9

Use it

Look up 67184-0531 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0531 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67184-0531. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.